1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of CYP 17

Details for Australian Patent Application No. 2010264698 (hide)

Owner Novartis AG

Inventors Bock, Mark G.; Gaul, Christoph; Gummadi, Venkateshwar Rao; Sengupta, Saumitra

Agent Davies Collison Cave

Pub. Number AU-B-2010264698

PCT Pub. Number WO2010/149755

Priority 2181/DEL/2009 21.10.09 IN; 1500/CHE/2009 26.06.09 IN

Filing date 24 June 2010

Wipo publication date 29 December 2010

Acceptance publication date 18 October 2012

International Classifications

C07D 403/04 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4178

A61P 35/00 Antineoplastic agents

C07D 403/14 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 407/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 417/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

8 December 2011 PCT application entered the National Phase

  PCT publication WO2010/149755 Priority application(s): WO2010/149755

18 October 2012 Application Accepted

  Published as AU-B-2010264698

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010264703-Mexiletine amino acid and peptide prodrugs and uses thereof

2010264695-Novel human papillomavirus (HPV) protein constructs and their use in the prevention of HPV disease